QURE

uniQure N.V. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-02

Figures on this page computed 2026-11-08 12:41 UTC

Last close

23.03USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-02

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001104659-26-021898
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-02
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001104659-26-021898
Reported in
USD
- 10-K for 2025, filed 2026-03-02
- 10-K for 2025, filed 2026-03-02
- 10-K for 2025, filed 2026-03-02
- 10-Q for 2025, filed 2026-05-05
- 10-K for 2025, filed 2026-03-02
- 10-Q for 2025, filed 2026-05-05
The filing itself
-1236.0%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-021898
Reported in
USD
- 10-K for 2025, filed 2026-03-02
- 10-K for 2025, filed 2026-03-02
The filing itself
-1108.2%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-021898
Reported in
USD
- 10-K for 2025, filed 2026-03-02
- 10-K for 2025, filed 2026-03-02
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001104659-26-021898
Reported in
USD
- 10-K for 2025, filed 2026-03-02
- 10-Q for 2025, filed 2026-05-05
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.09 against 0.38 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

0.21x

1.93x

2.00x

0.83x

0.89x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-02

Sales0.21x
Its own average over 10 years, 78.4M.
Profit1.93x
Its own average over 10 years, -102.9M.
Free cash flow2.00x
Its own average over 10 years, -89.1M.
Debt0.83x
Its own average over 10 years, 76.8M.
Price0.89x
Its own average over 11 years, 26. Market data, 2026-11-04

Free cash flow is furthest from its own average, at 2.00 times.

Sales is 0.21 times its own 10-year average; Profit is 1.93 times its own 10-year average; Free cash flow is 2.00 times its own 10-year average; Debt is 0.83 times its own 10-year average; Price is 0.89 times its own 11-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-02

Sales against its own 10-year average0.21
Source
filed
Statement
income
Fiscal year
2025
Accession
0001104659-26-021898
Reported in
USD
The filing itself
Profit against its own 10-year average1.93
Source
filed
Statement
income
Fiscal year
2025
Accession
0001104659-26-021898
Reported in
USD
The filing itself
Free cash flow against its own 10-year average2.00
Source
filed
Statement
income
Fiscal year
2025
Accession
0001104659-26-021898
Reported in
USD
The filing itself
Debt against its own 10-year average0.83
Source
filed
Statement
income
Fiscal year
2025
Accession
0001104659-26-021898
Reported in
USD
The filing itself
Price against its own 11-year average0.89Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD